The role of M1 and M2 macrophage polarization in progression of medication-related osteonecrosis of the jaw
Autor: | Christos Perisanidis, Boban M. Erovic, Ioannis Gkouveris, Georgios Kostakis, Evangelos Kalfarentzos, Emmanouil Vardas, Polytimi Paschalidi, Akrivoula Soundia, Nikolaos G. Nikitakis, Maria Georgaki, Sotirios Tetradis |
---|---|
Rok vydání: | 2020 |
Předmět: |
Pathology
medicine.medical_specialty Macrophage polarization Cell Count Article 03 medical and health sciences 0302 clinical medicine medicine Humans General Dentistry Bisphosphonate-associated osteonecrosis of the jaw Diphosphonates CD68 business.industry Macrophages Interleukin 030206 dentistry medicine.disease M2 Macrophage Denosumab Zoledronic acid 030220 oncology & carcinogenesis Bisphosphonate-Associated Osteonecrosis of the Jaw business Osteonecrosis of the jaw medicine.drug |
Zdroj: | Clin Oral Investig |
ISSN: | 1436-3771 1432-6981 |
DOI: | 10.1007/s00784-020-03602-z |
Popis: | OBJECTIVES: The aim of this study was to investigate the relationship between M1 and M2 macrophage polarization and clinical stage in patients with medication-related osteonecrosis of the jaw (MRONJ) who underwent treatment with bisphosphonates or denosumab. MATERIALS AND METHODS: M1 and M2 macrophage density and expression of interleukin (IL)-6 and IL-10 were assessed on biopsies of mucosal tissues surrounding necrotic bone in 30 MRONJ patients with stages 1–3 and controls. For identification of M1 and M2 macrophages, double CD68/iNOS and CD68/CD206 immunofluorescence staining was conducted, respectively. Computer-assisted immunofluorescence quantification of markers was performed. RESULTS: Early stage 1 MRONJ patients showed a switch toward the M2 phenotype, as indicated by the higher density of M2 macrophages, the decreased M1/M2 ratio and the upregulation of IL-10. MRONJ patients with advanced stages 2 and 3 showed a shift toward M1-polarized macrophages, as suggested by the higher density of M1 macrophages, the increased M1/M2 ratio and the overexpression of IL-6. The macrophage density of both M1 and M2 subsets was significantly enhanced in patients receiving bisphosphonates compared to those receiving denosumab. CONCLUSIONS: The M1–M2 macrophage polarization status in mucosal tissues bordering necrotic bone correlates with clinical stage of MRONJ. Patients with early stage MRONJ show a switch toward M2-polarized macrophages, while MRONJ patients with advanced stage demonstrate a shift toward the M1 phenotype. CLINICAL RELEVANCE: Therapeutic molecules targeting the inflammatory microenvironment via the regulation of either M1 or M2 macrophage polarization may represent a novel strategy for treatment of MRONJ. |
Databáze: | OpenAIRE |
Externí odkaz: |